Literature DB >> 30787438

β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration.

Dmitri Lodygin1, Moritz Hermann1, Francesca Odoardi2,3, Alexander Flügel4, Nils Schweingruber1, Cassandra Flügel-Koch5, Takashi Watanabe6, Corinna Schlosser1, Arianna Merlini1, Henrike Körner1, Hsin-Fang Chang1, Henrike J Fischer1, Holger M Reichardt7, Marta Zagrebelsky8, Brit Mollenhauer9,10, Sebastian Kügler10, Dirk Fitzner10, Jens Frahm6, Christine Stadelmann11, Michael Haberl1.   

Abstract

The grey matter is a central target of pathological processes in neurodegenerative disorders such as Parkinson's and Alzheimer's diseases. The grey matter is often also affected in multiple sclerosis, an autoimmune disease of the central nervous system. The mechanisms that underlie grey matter inflammation and degeneration in multiple sclerosis are not well understood. Here we show that, in Lewis rats, T cells directed against the neuronal protein β-synuclein specifically invade the grey matter and that this is accompanied by the presentation of multifaceted clinical disease. The expression pattern of β-synuclein induces the local activation of these T cells and, therefore, determined inflammatory priming of the tissue and targeted recruitment of immune cells. The resulting inflammation led to significant changes in the grey matter, which ranged from gliosis and neuronal destruction to brain atrophy. In humans, β-synuclein-specific T cells were enriched in patients with chronic-progressive multiple sclerosis. These findings reveal a previously unrecognized role of β-synuclein in provoking T-cell-mediated pathology of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30787438     DOI: 10.1038/s41586-019-0964-2

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1 in total

1.  Complexity and sequence identification of 24 rat V beta genes.

Authors:  L R Smith; D H Kono; A N Theofilopoulos
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

  1 in total
  48 in total

Review 1.  Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions.

Authors:  Ariele L Greenfield; Stephen L Hauser
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 2.  Aging and Rejuvenation of Neural Stem Cells and Their Niches.

Authors:  Paloma Navarro Negredo; Robin W Yeo; Anne Brunet
Journal:  Cell Stem Cell       Date:  2020-07-28       Impact factor: 24.633

Review 3.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

4.  Anti-αLβ2 antibodies reveal novel endocytotic cross-modulatory functionality.

Authors:  Riccardo V Mancuso; Jens Casper; Albrecht G Schmidt; Stephan Krähenbühl; Gabriele Weitz-Schmidt
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

5.  Phagocyte-mediated synapse removal in cortical neuroinflammation is promoted by local calcium accumulation.

Authors:  Mehrnoosh Jafari; Adrian-Minh Schumacher; Nicolas Snaidero; Emily M Ullrich Gavilanes; Tradite Neziraj; Virág Kocsis-Jutka; Daniel Engels; Tanja Jürgens; Ingrid Wagner; Juan Daniel Flórez Weidinger; Stephanie S Schmidt; Eduardo Beltrán; Nellwyn Hagan; Lisa Woodworth; Dimitry Ofengeim; Joseph Gans; Fred Wolf; Mario Kreutzfeldt; Ruben Portugues; Doron Merkler; Thomas Misgeld; Martin Kerschensteiner
Journal:  Nat Neurosci       Date:  2021-01-25       Impact factor: 24.884

Review 6.  Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.

Authors:  Cecilia S Lindestam Arlehamn; Francesca Garretti; David Sulzer; Alessandro Sette
Journal:  Curr Opin Immunol       Date:  2019-08-17       Impact factor: 7.486

Review 7.  The immunology of multiple sclerosis.

Authors:  Kathrine E Attfield; Lise Torp Jensen; Max Kaufmann; Manuel A Friese; Lars Fugger
Journal:  Nat Rev Immunol       Date:  2022-05-04       Impact factor: 53.106

Review 8.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

Review 9.  Brain Parenchymal and Extraparenchymal Macrophages in Development, Homeostasis, and Disease.

Authors:  Simone Brioschi; Yingyue Zhou; Marco Colonna
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

Review 10.  B cells in autoimmune and neurodegenerative central nervous system diseases.

Authors:  Joseph J Sabatino; Anne-Katrin Pröbstel; Scott S Zamvil
Journal:  Nat Rev Neurosci       Date:  2019-11-11       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.